Alnylam Pharmaceuticals, Inc. (ALNY)
328.08
+8.56
(+2.68%)
USD |
NASDAQ |
Apr 08, 13:14
Alnylam Pharmaceuticals Cash from Investing (TTM) : 436.33M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Pfizer Inc. | -1.351B |
| Eli Lilly & Co. | -10.97B |
| Bristol Myers Squibb Co. | -4.132B |
| Ionis Pharmaceuticals, Inc. | -277.78M |
| Regeneron Pharmaceuticals, Inc. | -629.10M |